Fig. 9

Pharmacological effects and statistical analysis of M-PDA@8G in the treatment of SCI (A, B) Quantification of NF200 and MBP in immunofluorescence sections of spinal cord by ImageJ (n = 4). C, E Levels of GSH, SOD, and MDA in the spinal cord of different experimental groups on the 14th day after injury (n = 3). F, G Effects of different treatments on GPX4, 15-LOX-2, 4-HNE, IL-1β, and TNF-α levels on day 14 post-injury detected by Western blotting. (H-L). Quantitative analysis of the indicators imaged in F, G (n = 3)